GILMAN STEVEN C
Insider CIK 1379970 · KERX Director · SCYX Director · MNTA Director · CFRX Interim CEO, Director · AKBA Director · VCEL Director · CBST EVP & Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SCYX SCYNEXIS INC | A Award deriv | 2025-06-26 | 2025-06-30 | 23,000 | — | $0 | 23,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2025-06-26 | 2025-06-30 | 23,000 | — | $0 | 70,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-11 | 53,600 | — | $0 | 53,600 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2025-06-10 | 2025-06-11 | 35,700 | — | $0 | 152,830 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2024-10-16 | 2024-10-18 | 5,833 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2024-10-16 | 2024-10-18 | 5,833 | $41.36 | $241.3K | 11,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2024-10-16 | 2024-10-18 | 5,833 | $13.05 | $76.1K | 16,833 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2024-10-02 | 2024-10-04 | 5,833 | — | $0 | 5,833 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2024-10-02 | 2024-10-04 | 5,833 | $40.35 | $235.4K | 11,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2024-10-02 | 2024-10-04 | 5,833 | $13.05 | $76.1K | 16,833 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2024-09-18 | 2024-09-20 | 5,834 | — | $0 | 11,666 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2024-09-18 | 2024-09-20 | 5,834 | $45.54 | $265.7K | 11,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2024-09-18 | 2024-09-20 | 5,834 | $13.05 | $76.1K | 16,834 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2024-09-04 | 2024-09-05 | 5,000 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2024-09-04 | 2024-09-05 | 5,000 | $48.58 | $242.9K | 11,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2024-09-04 | 2024-09-05 | 5,000 | $3.74 | $18.7K | 16,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2024-06-20 | 2024-06-21 | 23,000 | — | $0 | 23,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2024-06-20 | 2024-06-21 | 23,000 | — | $0 | 47,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2024-06-06 | 2024-06-10 | 30,000 | — | $0 | 117,130 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2024-05-01 | 2024-05-03 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2024-05-01 | 2024-05-03 | 3,200 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2024-05-01 | 2024-05-03 | 3,200 | — | $0 | 3,200 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2024-05-01 | 2024-05-03 | 3,200 | — | $0 | 11,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2023-06-15 | 2023-06-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2023-06-15 | 2023-06-23 | 10,000 | — | $0 | 24,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 87,130 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2023-05-03 | 2023-05-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2023-05-03 | 2023-05-05 | 3,200 | — | $0 | 3,200 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2023-04-27 | 2023-04-28 | 2,600 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2023-04-27 | 2023-04-28 | 2,600 | — | $0 | 7,800 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2022-06-17 | 2022-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2022-06-17 | 2022-06-22 | 10,000 | — | $0 | 14,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2022-06-08 | 2022-06-09 | 13,700 | — | $0 | 57,130 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-06-03 | 2022-06-07 | 4,567 | $0.36 | $1.6K | 43,430 | SEC↗ |
| CFRX CONTRAFECT Corp | A Award deriv | 2022-05-17 | 2022-05-18 | 42,000 | $3.35 | $140.7K | 42,000 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2022-04-29 | 2022-05-02 | 900 | $30.94 | $27.8K | 5,200 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2022-04-27 | 2022-04-29 | 2,600 | — | $0 | 2,600 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2022-04-27 | 2022-04-29 | 6,500 | — | $0 | 6,500 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2022-04-27 | 2022-04-29 | 2,600 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2022-04-27 | 2022-04-29 | 2,600 | — | $0 | 6,100 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2021-11-29 | 2021-12-01 | 5,000 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2021-11-29 | 2021-12-01 | 5,000 | $39.17 | $195.8K | 3,500 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2021-11-29 | 2021-12-01 | 5,000 | $3.74 | $18.7K | 8,500 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2021-10-27 | 2021-10-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2021-10-27 | 2021-10-28 | 5,000 | $3.74 | $18.7K | 8,500 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2021-10-27 | 2021-10-28 | 5,000 | $50.57 | $252.8K | 3,500 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2021-09-30 | 2021-10-01 | 5,000 | — | $0 | 10,000 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2021-09-30 | 2021-10-01 | 5,000 | $48.85 | $244.3K | 3,500 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2021-09-30 | 2021-10-01 | 5,000 | $3.74 | $18.7K | 8,500 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2021-06-16 | 2021-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-06-07 | 2021-06-09 | 4,567 | $3.32 | $15.2K | 47,997 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2021-06-02 | 2021-06-03 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-06-02 | 2021-06-03 | 13,700 | — | $0 | 52,564 | SEC↗ |
| CFRX CONTRAFECT Corp | A Award deriv | 2021-05-18 | 2021-05-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2021-04-28 | 2021-04-30 | 1,750 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2021-04-28 | 2021-04-30 | 2,600 | — | $0 | 2,600 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2021-04-28 | 2021-04-30 | 6,500 | — | $0 | 6,500 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2021-04-28 | 2021-04-30 | 1,750 | — | $0 | 3,500 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-12-21 | 2020-12-23 | 2,000 | — | $0 | 2,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-12-21 | 2020-12-23 | 2,000 | — | $0 | 2,000 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy | 2020-12-21 | 2020-12-23 | 4,000 | $6.25 | $25.0K | 4,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 8,855 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 25,000 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 25,000 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer deriv | 2020-10-01 | 2020-10-01 | 11,207 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | D To issuer | 2020-10-01 | 2020-10-01 | 7,796 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2020-08-05 | 2020-08-07 | 13,000 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-08-05 | 2020-08-07 | 13,000 | $32.75 | $425.8K | 7,796 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2020-08-05 | 2020-08-07 | 13,000 | $10.63 | $138.2K | 20,796 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2020-07-29 | 2020-07-30 | 10,000 | — | $0 | 13,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-07-29 | 2020-07-30 | 10,000 | $29.70 | $297.0K | 7,796 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2020-07-29 | 2020-07-30 | 10,000 | $10.63 | $106.3K | 17,796 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2020-07-22 | 2020-07-23 | 10,000 | — | $0 | 23,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award | 2020-07-22 | 2020-07-23 | 10,000 | $10.63 | $106.3K | 17,796 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2020-07-22 | 2020-07-23 | 10,000 | $33.23 | $332.3K | 7,796 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-07-06 | 2021-03-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-07-06 | 2020-07-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2020-06-23 | 2020-06-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2020-06-08 | 2020-06-09 | 4,567 | $12.08 | $55.2K | 38,864 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2020-06-05 | 2020-06-09 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2020-06-05 | 2020-06-09 | 13,700 | — | $0 | 43,431 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2020-04-29 | 2020-05-01 | 1,750 | — | $0 | 1,750 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2020-04-29 | 2020-05-01 | 13,125 | — | $0 | 13,125 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2020-04-29 | 2020-05-01 | 1,750 | $14.56 | $25.5K | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2020-04-29 | 2020-05-01 | 1,750 | — | $0 | 1,750 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2019-11-20 | 2019-11-22 | 5,800 | $3.43 | $19.9K | 29,731 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2019-06-20 | 2019-06-21 | 4,356 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2019-06-20 | 2019-06-21 | 4,356 | — | $0 | 7,796 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2019-06-19 | 2019-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2019-06-18 | 2019-06-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-06-06 | 2019-06-10 | 13,700 | — | $0 | 23,931 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2019-05-01 | 2019-05-03 | 13,125 | — | $0 | 13,125 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2019-05-01 | 2019-05-03 | 1,750 | — | $0 | 1,750 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2019-05-01 | 2019-05-03 | 7,500 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2019-05-01 | 2019-05-03 | 7,500 | $2.76 | $20.7K | 7,500 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2019-05-01 | 2019-05-03 | 7,500 | $16.81 | $126.1K | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2019-02-28 | 2019-03-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2019-02-28 | 2019-03-04 | 7,500 | $18.02 | $135.2K | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2019-02-28 | 2019-03-04 | 7,500 | $2.76 | $20.7K | 7,500 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2019-01-02 | 2019-01-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | D To issuer deriv | 2018-12-12 | 2018-12-13 | 140,000 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 18,716 | — | $0 | 18,716 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 11,229 | — | $0 | 11,229 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 11,229 | — | $0 | 11,229 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 11,229 | — | $0 | 11,229 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | D To issuer | 2018-12-12 | 2018-12-13 | 27,333 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2018-12-12 | 2018-12-13 | 10,231 | — | $0 | 10,231 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2018-12-03 | 2018-12-04 | 8,500 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2018-12-03 | 2018-12-04 | 8,500 | $2.63 | $22.4K | 8,500 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2018-12-03 | 2018-12-04 | 8,500 | $17.75 | $150.9K | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2018-09-04 | 2018-09-06 | 9,000 | — | $0 | 8,500 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2018-09-04 | 2018-09-06 | 9,000 | $2.63 | $23.7K | 9,000 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2018-09-04 | 2018-09-06 | 9,000 | $12.03 | $108.3K | 0 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2018-06-30 | 2018-07-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2018-06-30 | 2018-07-12 | 10,000 | — | $0 | 27,333 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | S Sale | 2018-06-22 | 2018-06-26 | 2,294 | $21.50 | $49.3K | 3,440 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2018-06-20 | 2018-06-22 | 4,356 | — | $0 | 4,356 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise deriv | 2018-06-20 | 2018-06-22 | 5,734 | — | $0 | 0 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2018-06-20 | 2018-06-22 | 8,855 | — | $0 | 8,855 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | M Exercise | 2018-06-20 | 2018-06-22 | 5,734 | — | $0 | 5,734 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2018-06-11 | 2018-06-12 | 1,334 | $5.12 | $6.8K | 17,333 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2018-05-29 | 2018-05-31 | 1,333 | $5.22 | $7.0K | 18,667 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2018-05-02 | 2018-05-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2018-01-02 | 2018-01-04 | 19,989 | — | $0 | 19,989 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-10-02 | 2017-10-04 | 1,807 | — | $0 | 1,807 | SEC↗ |
| CFRX CONTRAFECT Corp | P Buy deriv | 2017-07-25 | 2017-07-26 | 400 | $0.01 | $4 | 400 | SEC↗ |
| CFRX CONTRAFECT Corp | P Buy | 2017-07-25 | 2017-07-26 | 800 | $1.24 | $992 | 20,800 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-07-03 | 2017-07-05 | 2,430 | — | $0 | 2,430 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2017-06-20 | 2017-06-22 | 11,207 | — | $0 | 11,207 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2017-06-20 | 2017-06-22 | 5,734 | — | $0 | 5,734 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2017-06-09 | 2017-06-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2017-06-09 | 2017-06-20 | 10,000 | — | $0 | 20,000 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2017-05-03 | 2017-05-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-04-03 | 2017-04-04 | 1,678 | — | $0 | 1,678 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-01-03 | 2017-01-05 | 1,308 | — | $0 | 1,308 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-01-03 | 2017-01-05 | 14,499 | — | $0 | 14,499 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2016-10-03 | 2016-10-04 | 977 | — | $0 | 977 | SEC↗ |
| CFRX CONTRAFECT Corp | P Buy deriv | 2016-07-27 | 2016-07-27 | 20,000 | $0.02 | $400 | 20,000 | SEC↗ |
| CFRX CONTRAFECT Corp | P Buy | 2016-07-27 | 2016-07-27 | 20,000 | $2.48 | $49.6K | 20,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2016-07-01 | 2016-07-11 | 2,030 | — | $0 | 2,030 | SEC↗ |
| MNTA MOMENTA PHARMACEUTICALS IN | A Award deriv | 2016-06-22 | 2016-06-24 | 33,000 | — | $0 | 33,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2016-06-02 | 2016-06-06 | 8,800 | $3.98 | $35.0K | 8,800 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2016-05-26 | 2016-05-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2016-05-26 | 2016-05-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2016-05-04 | 2016-05-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2016-04-01 | 2016-04-05 | 1,098 | — | $0 | 1,098 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2016-01-04 | 2016-01-06 | 729 | — | $0 | 729 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-10-01 | 2015-10-05 | 670 | — | $0 | 670 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-07-01 | 2015-07-06 | 502 | — | $0 | 502 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-06-04 | 2015-06-05 | 8,800 | — | $0 | 8,800 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-04-01 | 2015-04-03 | 554 | — | $0 | 544 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2015-03-20 | 2015-03-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-02-25 | 2015-02-27 | 486 | — | $0 | 486 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-02-25 | 2015-02-27 | 7,830 | — | $0 | 7,830 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 4,046 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 4,552 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 31,053 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 7,812 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 5,859 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 47,851 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 7,500 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 75,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 21,875 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 3,500 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 9,375 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 60,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 1,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2015-01-21 | 2015-01-21 | 27,680 | $102.00 | $2.82M | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2015-01-21 | 2015-01-21 | 2,851 | $102.00 | $290.8K | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2014-12-31 | 2015-01-05 | 82 | $59.96 | $4.9K | 27,680 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-10-01 | 2014-10-02 | 48,125 | — | $0 | 21,875 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-10-01 | 2014-10-02 | 25,500 | $65.11 | $1.66M | 50,223 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-10-01 | 2014-10-02 | 400 | $66.50 | $26.6K | 27,598 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-10-01 | 2014-10-02 | 22,225 | $65.68 | $1.46M | 27,998 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-10-01 | 2014-10-02 | 48,125 | $65.39 | $3.15M | 75,723 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-07-28 | 2014-07-29 | 34,100 | — | $0 | 15,900 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-07-28 | 2014-07-29 | 6,525 | — | $0 | 9,375 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-07-28 | 2014-07-29 | 6,525 | $62.44 | $407.4K | 27,598 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-07-28 | 2014-07-29 | 34,100 | $61.40 | $2.09M | 34,123 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-07-28 | 2014-07-29 | 6,525 | $25.23 | $164.6K | 68,223 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-07-28 | 2014-07-29 | 34,100 | $25.23 | $860.3K | 61,698 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2014-06-30 | 2014-07-02 | 107 | $69.82 | $7.5K | 2,851 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-05-15 | 2014-05-15 | 15,125 | — | $0 | 1,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-05-15 | 2014-05-15 | 6,225 | $68.42 | $425.9K | 27,598 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-05-15 | 2014-05-15 | 1,215 | $67.50 | $82.0K | 27,598 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-05-15 | 2014-05-15 | 15,125 | $16.76 | $253.5K | 42,723 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-05-15 | 2014-05-15 | 8,900 | $67.45 | $600.3K | 33,823 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-05-14 | 2014-05-15 | 2,500 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-05-14 | 2014-05-14 | 1,680 | $69.00 | $115.9K | 26,313 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-05-14 | 2014-05-15 | 2,500 | — | $0 | 28,813 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-05-13 | 2014-05-14 | 3,500 | — | $0 | 3,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-05-13 | 2014-05-14 | 3,500 | — | $0 | 27,993 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2014-03-31 | 2014-04-02 | 111 | $73.15 | $8.1K | 2,744 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-02-18 | 2014-02-19 | 2,645 | $75.00 | $198.4K | 24,493 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-02-16 | 2014-02-19 | 3,750 | — | $0 | 7,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-02-16 | 2014-02-19 | 3,750 | — | $0 | 27,138 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-02-15 | 2014-02-19 | 1,953 | — | $0 | 5,859 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-02-15 | 2014-02-19 | 1,953 | — | $0 | 23,388 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-02-14 | 2014-02-19 | 4,046 | — | $0 | 4,046 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-02-14 | 2014-02-19 | 4,552 | — | $0 | 4,552 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-02-14 | 2014-02-19 | 31,053 | — | $0 | 31,053 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-01-02 | 2014-01-02 | 25,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-01-02 | 2014-01-02 | 25,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-01-02 | 2014-01-02 | 510 | $68.65 | $35.0K | 23,540 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-01-02 | 2014-01-02 | 24,490 | $67.80 | $1.66M | 24,050 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-01-02 | 2014-01-02 | 25,000 | $18.69 | $467.3K | 48,540 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-01-02 | 2014-01-02 | 510 | $68.65 | $35.0K | 22,778 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-01-02 | 2014-01-02 | 24,490 | $67.80 | $1.66M | 23,288 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-01-02 | 2014-01-02 | 25,000 | $18.69 | $467.3K | 47,778 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2014-01-02 | 2014-01-06 | 190 | — | $0 | 21,625 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2014-01-02 | 2014-01-06 | 190 | — | $0 | 21,435 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-31 | 2014-01-02 | 188 | — | $0 | 23,429 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2013-12-31 | 2014-01-02 | 111 | $42.59 | $4.7K | 23,540 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2013-12-31 | 2014-01-02 | 111 | $42.59 | $4.7K | 22,778 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-31 | 2014-01-02 | 188 | — | $0 | 21,704 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-30 | 2014-01-02 | 190 | — | $0 | 23,241 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-30 | 2014-01-02 | 190 | — | $0 | 21,892 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-27 | 2014-01-02 | 192 | — | $0 | 23,051 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-27 | 2014-01-02 | 192 | — | $0 | 22,859 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-27 | 2014-01-02 | 192 | — | $0 | 22,082 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-27 | 2014-01-02 | 192 | — | $0 | 22,859 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-23 | 2014-01-02 | 195 | — | $0 | 22,466 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-23 | 2014-01-02 | 195 | — | $0 | 22,661 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-23 | 2014-01-02 | 195 | — | $0 | 22,856 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-19 | 2013-12-20 | 195 | — | $0 | 23,246 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-19 | 2013-12-20 | 195 | — | $0 | 23,441 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2013-12-19 | 2013-12-20 | 195 | — | $0 | 23,051 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2013-06-28 | 2013-07-02 | 154 | $48.29 | $7.4K | 2,633 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2013-06-28 | 2013-07-02 | 129 | $36.69 | $4.7K | 23,636 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-06-03 | 2013-06-03 | 15,125 | — | $0 | 16,125 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-06-03 | 2013-06-03 | 15,125 | $54.49 | $824.2K | 23,507 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-06-03 | 2013-06-03 | 15,125 | $16.76 | $253.5K | 38,632 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-05-16 | 2013-05-17 | 1,201 | $48.88 | $58.7K | 23,507 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-05-15 | 2013-05-17 | 2,500 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-05-15 | 2013-05-16 | 1,017 | $48.41 | $49.2K | 22,208 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-05-15 | 2013-05-17 | 2,500 | — | $0 | 24,708 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-05-14 | 2013-05-16 | 2,500 | — | $0 | 2,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-05-14 | 2013-05-15 | 1,135 | $49.18 | $55.8K | 20,725 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-05-14 | 2013-05-16 | 2,500 | — | $0 | 23,225 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-05-13 | 2013-05-15 | 3,500 | — | $0 | 7,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-05-13 | 2013-05-15 | 3,500 | — | $0 | 21,860 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2013-03-28 | 2013-04-02 | 167 | $46.82 | $7.8K | 445 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-02-19 | 2013-02-20 | 1,233 | $41.40 | $51.0K | 18,360 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-02-16 | 2013-02-20 | 3,750 | — | $0 | 11,250 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-02-16 | 2013-02-20 | 3,750 | — | $0 | 19,593 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-02-15 | 2013-02-20 | 7,812 | — | $0 | 7,812 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-02-15 | 2013-02-20 | 47,851 | — | $0 | 47,851 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-02-15 | 2013-02-20 | 7,812 | — | $0 | 7,812 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-01-02 | 2013-01-03 | 15,000 | — | $0 | 25,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-01-02 | 2013-01-03 | 15,000 | $42.98 | $644.7K | 15,843 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-01-02 | 2013-01-03 | 15,000 | $18.69 | $280.4K | 30,843 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2012-12-31 | 2013-01-03 | 138 | $33.12 | $4.6K | 15,843 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2012-08-29 | 2012-08-30 | 217 | — | $0 | 16,139 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2012-08-29 | 2012-08-30 | 217 | — | $0 | 15,922 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | G Gift | 2012-08-29 | 2012-08-30 | 217 | — | $0 | 15,705 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2012-06-29 | 2012-07-03 | 142 | $32.22 | $4.6K | 18,521 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2012-06-29 | 2012-07-03 | 147 | $37.91 | $5.6K | 2,181 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-17 | 2012-05-17 | 20,000 | — | $0 | 40,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-05-17 | 2012-05-17 | 20,000 | $41.57 | $831.4K | 18,379 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-17 | 2012-05-17 | 20,000 | $18.69 | $373.8K | 38,379 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-05-16 | 2012-05-16 | 798 | $41.85 | $33.4K | 18,379 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-15 | 2012-05-16 | 2,500 | — | $0 | 2,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-05-15 | 2012-05-16 | 799 | $41.90 | $33.5K | 19,177 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-15 | 2012-05-16 | 2,500 | — | $0 | 19,976 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-14 | 2012-05-16 | 2,500 | — | $0 | 5,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-05-14 | 2012-05-15 | 1,135 | $41.55 | $47.2K | 14,976 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-14 | 2012-05-16 | 2,500 | — | $0 | 17,476 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-13 | 2012-05-15 | 3,500 | — | $0 | 10,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-13 | 2012-05-15 | 3,500 | — | $0 | 16,111 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2012-03-30 | 2012-04-03 | 131 | $43.25 | $5.7K | 12,611 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-02-16 | 2012-02-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-02-16 | 2012-02-21 | 75,000 | — | $0 | 75,000 | SEC↗ |